Cargando…
Symptoms, Management and Healthcare Utilization of COPD Patients During the COVID-19 Epidemic in Beijing
BACKGROUND: Social distancing and restriction measures during the COVID-19 epidemic may have impacts on medication availability and healthcare utilization for COPD patients, and thereby affect standard disease management. We aimed to investigate the change of respiratory symptoms, pharmacological tr...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7569036/ https://www.ncbi.nlm.nih.gov/pubmed/33116465 http://dx.doi.org/10.2147/COPD.S270448 |
_version_ | 1783596644152901632 |
---|---|
author | Liang, Ying Chang, Chun Chen, Yahong Dong, Fawu Zhang, Linlin Sun, Yongchang |
author_facet | Liang, Ying Chang, Chun Chen, Yahong Dong, Fawu Zhang, Linlin Sun, Yongchang |
author_sort | Liang, Ying |
collection | PubMed |
description | BACKGROUND: Social distancing and restriction measures during the COVID-19 epidemic may have impacts on medication availability and healthcare utilization for COPD patients, and thereby affect standard disease management. We aimed to investigate the change of respiratory symptoms, pharmacological treatment and healthcare utilization of COPD patients during the epidemic in Beijing, China. METHODS: We conducted a single-center, cross-sectional survey performed at Peking University Third Hospital and recruited patients with COPD who were interviewed by phone call. Clinical data, including respiratory symptoms, pharmacological treatment, management and healthcare access before and during the COVID-19 epidemic from January 25 to April 25, 2020, were collected. RESULTS: A total of 153 patients were enrolled for analysis. Before the epidemic, 81.7% (125/153) had long-term maintenance medication and ICS/LABA (60.8%) and LAMA (57.5%) were most commonly used. During the epidemic, 75.2% (115/153) maintained their pharmacological treatment and 6.5% (10/153) had to reduce or stop taking medications, with a slight decrease of patients taking ICS/LABA (53.6%) and LAMA (56.9%). Most of the patients [76.5% (117/153)] had a low symptom burden, with a CAT score <10 during the epidemic. Of 153 patients, 45 (29.4%) patients reported worsening of respiratory symptoms but only 15.6% (7/45) sought medical care in hospitals, while the remaining expressed concerns about cross-infection in the hospital (55.5%, 25/45) or had mild symptoms which were managed by themselves (28.8%, 13/45). CONCLUSION: During the COVID-19 epidemic in Beijing, most of our COPD patients maintained their long-term pharmacological treatment and had mild-to-moderate symptoms. Approximately, 30.0% of the patients experienced worsening of respiratory symptoms, but most of them did not seek medical care in the hospital due to concerns about cross-infection. |
format | Online Article Text |
id | pubmed-7569036 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Dove |
record_format | MEDLINE/PubMed |
spelling | pubmed-75690362020-10-27 Symptoms, Management and Healthcare Utilization of COPD Patients During the COVID-19 Epidemic in Beijing Liang, Ying Chang, Chun Chen, Yahong Dong, Fawu Zhang, Linlin Sun, Yongchang Int J Chron Obstruct Pulmon Dis Original Research BACKGROUND: Social distancing and restriction measures during the COVID-19 epidemic may have impacts on medication availability and healthcare utilization for COPD patients, and thereby affect standard disease management. We aimed to investigate the change of respiratory symptoms, pharmacological treatment and healthcare utilization of COPD patients during the epidemic in Beijing, China. METHODS: We conducted a single-center, cross-sectional survey performed at Peking University Third Hospital and recruited patients with COPD who were interviewed by phone call. Clinical data, including respiratory symptoms, pharmacological treatment, management and healthcare access before and during the COVID-19 epidemic from January 25 to April 25, 2020, were collected. RESULTS: A total of 153 patients were enrolled for analysis. Before the epidemic, 81.7% (125/153) had long-term maintenance medication and ICS/LABA (60.8%) and LAMA (57.5%) were most commonly used. During the epidemic, 75.2% (115/153) maintained their pharmacological treatment and 6.5% (10/153) had to reduce or stop taking medications, with a slight decrease of patients taking ICS/LABA (53.6%) and LAMA (56.9%). Most of the patients [76.5% (117/153)] had a low symptom burden, with a CAT score <10 during the epidemic. Of 153 patients, 45 (29.4%) patients reported worsening of respiratory symptoms but only 15.6% (7/45) sought medical care in hospitals, while the remaining expressed concerns about cross-infection in the hospital (55.5%, 25/45) or had mild symptoms which were managed by themselves (28.8%, 13/45). CONCLUSION: During the COVID-19 epidemic in Beijing, most of our COPD patients maintained their long-term pharmacological treatment and had mild-to-moderate symptoms. Approximately, 30.0% of the patients experienced worsening of respiratory symptoms, but most of them did not seek medical care in the hospital due to concerns about cross-infection. Dove 2020-10-14 /pmc/articles/PMC7569036/ /pubmed/33116465 http://dx.doi.org/10.2147/COPD.S270448 Text en © 2020 Liang et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
spellingShingle | Original Research Liang, Ying Chang, Chun Chen, Yahong Dong, Fawu Zhang, Linlin Sun, Yongchang Symptoms, Management and Healthcare Utilization of COPD Patients During the COVID-19 Epidemic in Beijing |
title | Symptoms, Management and Healthcare Utilization of COPD Patients During the COVID-19 Epidemic in Beijing |
title_full | Symptoms, Management and Healthcare Utilization of COPD Patients During the COVID-19 Epidemic in Beijing |
title_fullStr | Symptoms, Management and Healthcare Utilization of COPD Patients During the COVID-19 Epidemic in Beijing |
title_full_unstemmed | Symptoms, Management and Healthcare Utilization of COPD Patients During the COVID-19 Epidemic in Beijing |
title_short | Symptoms, Management and Healthcare Utilization of COPD Patients During the COVID-19 Epidemic in Beijing |
title_sort | symptoms, management and healthcare utilization of copd patients during the covid-19 epidemic in beijing |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7569036/ https://www.ncbi.nlm.nih.gov/pubmed/33116465 http://dx.doi.org/10.2147/COPD.S270448 |
work_keys_str_mv | AT liangying symptomsmanagementandhealthcareutilizationofcopdpatientsduringthecovid19epidemicinbeijing AT changchun symptomsmanagementandhealthcareutilizationofcopdpatientsduringthecovid19epidemicinbeijing AT chenyahong symptomsmanagementandhealthcareutilizationofcopdpatientsduringthecovid19epidemicinbeijing AT dongfawu symptomsmanagementandhealthcareutilizationofcopdpatientsduringthecovid19epidemicinbeijing AT zhanglinlin symptomsmanagementandhealthcareutilizationofcopdpatientsduringthecovid19epidemicinbeijing AT sunyongchang symptomsmanagementandhealthcareutilizationofcopdpatientsduringthecovid19epidemicinbeijing |